0000000000195396

AUTHOR

Iris Bischoff

showing 6 related works from this author

Macrophage-mediated angiogenic activation of outgrowth endothelial cells in co-culture with primary osteoblasts.

2014

The successful vascularisation of complex tissue engineered constructs for bone regeneration is still a major challenge in the field of tissue engineering. In this context, co-culture systems of endothelial cells and osteoblasts represent a promising approach to advance the formation of a stable vasculature as well as an excellent in vitro model to identify factors that positively influence bone healing processes, including angiogenesis. Under physiological conditions, the activation phase of angiogenesis is mainly induced by hypoxia or inflammation. Inflammatory cells such as macrophages secrete proinflammatory cytokines and proangiogenic growth factors, finally leading to the formation of…

Bone Regenerationlcsh:Diseases of the musculoskeletal systemAngiogenesislcsh:SurgeryNeovascularization PhysiologicInflammationBone healingBone and BonesProinflammatory cytokineTissue engineeringCell Line TumormedicineHumansBone regenerationOsteoblastsTissue EngineeringCell adhesion moleculeChemistryMacrophagesEndothelial CellsCell Differentiationlcsh:RD1-811Coculture TechniquesCell biologyCulture Media ConditionedMicrovesselsImmunologyCytokinesTumor necrosis factor alphalcsh:RC925-935medicine.symptom
researchProduct

Back Cover: Promoter Activation in Δ hfq Mutants as an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing (Ange…

2019

chemistry.chemical_compoundbiologyBiochemistryChemistryMetaboliteMutantINTCover (algebra)General ChemistryProteobacteriabiology.organism_classificationCatalysisAngewandte Chemie International Edition
researchProduct

Rücktitelbild: Promoter Activation in Δ hfq Mutants as an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing (A…

2019

chemistry.chemical_compoundBiochemistryChemistryMetaboliteMutantGeneral MedicineAngewandte Chemie
researchProduct

Promoter Activation in Dhfq Mutants as an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing

2019

Abstract Natural products (NPs) from microorganisms have been important sources for discovering new therapeutic and chemical entities. While their corresponding biosynthetic gene clusters (BGCs) can be easily identified by gene‐sequence‐similarity‐based bioinformatics strategies, the actual access to these NPs for structure elucidation and bioactivity testing remains difficult. Deletion of the gene encoding the RNA chaperone, Hfq, results in strains losing the production of most NPs. By exchanging the native promoter of a desired BGC against an inducible promoter in Δhfq mutants, almost exclusive production of the corresponding NP from the targeted BGC in Photorhabdus, Xenorhabdus and Pseud…

bioactivity testingnatural productsMetaboliteMutantPeptide SynthetasesXenorhabdus010402 general chemistry01 natural sciencesCatalysisBiosynthesis | Very Important Paperchemistry.chemical_compoundddc:570RNA chaperoneHumansMetabolomicsGeneResearch ArticlesBiological Productsbiology010405 organic chemistryPseudomonastechnology industry and agricultureGeneral MedicineGeneral Chemistrybiology.organism_classification0104 chemical sciencesBiosynthetic PathwayseasyPACIdchemistryBiochemistryddc:540proteobacteriaPhotorhabdussimplified productionResearch Article
researchProduct

Short‐term hypoxia promotes vascularization in co‐culture system consisting of primary human osteoblasts and outgrowth endothelial cells

2019

Prevascularization of tissue constructs before implantation has been developed as a novel and promising concept for successful implantation. Since hypoxia might induce angiogenesis, we have investigated the effects of hypoxic treatment on vascularization by using co-cultures of primary human osteoblasts (POBs) and outgrowth endothelial cells. Our results show that: (a) repeated short-term hypoxia (2% O2 for 8 hr), not long-term hypoxia (2% O2 for 24 hr), over 1 or 2 weeks, significantly enhances microvessel formation in co-cultures; (b) sustained hypoxia, not short-term or long-term hypoxia, causes cytotoxicity in mono- and co-cultures; (c) the expression of some angiogenic and inflammatory…

Time FactorsMaterials scienceCell SurvivalAngiogenesisProtein subunitmedicine.medical_treatment0206 medical engineeringBiomedical EngineeringNeovascularization Physiologic02 engineering and technologyBone tissueBiomaterialschemistry.chemical_compoundmedicineHumansRNA MessengerCytotoxicityMicrovesselCells CulturedOsteoblastsCell DeathGrowth factorMetals and AlloysEndothelial CellsHypoxia (medical)021001 nanoscience & nanotechnology020601 biomedical engineeringCell HypoxiaCoculture TechniquesUp-RegulationVascular endothelial growth factormedicine.anatomical_structurechemistryCeramics and CompositesCancer researchInflammation Mediatorsmedicine.symptom0210 nano-technologyJournal of Biomedical Materials Research Part A
researchProduct

In vitro evaluation of a biomaterial-based anticancer drug delivery system as an alternative to conventional post-surgery bone cancer treatment

2018

Patients diagnosed with osteosarcoma are currently treated with intravenous injections of anticancer agents after tumor resection. However, due to remaining neoplastic cells at the site of tumor removal, cancer recurrence often occurs. Successful bone regeneration combined with the control of residual cancer cells presents a challenge for tissue engineering. Cyclodextrins loaded with chemotherapeutic drugs reversibly release the drugs over time. Hydroxyapatite bone biomaterials coated with doxorubicin-loaded cyclodextrin should release the drug with time after implantation directly at the original tumor site and may be a way to eliminate residual neoplastic cells. In the present study, we h…

0301 basic medicineMaterials scienceBone NeoplasmsBioengineeringBiomaterials03 medical and health sciencesDrug Delivery Systems0302 clinical medicineTissue engineeringHuman Umbilical Vein Endothelial Cellspolycyclic compoundsmedicineHumansCytotoxic T cellDoxorubicinBone regenerationPostoperative CareCyclodextrinsOsteosarcomaAntibiotics AntineoplasticOsteoblastsBone cancermedicine.diseaseDurapatite030104 developmental biologyDoxorubicinMechanics of Materials030220 oncology & carcinogenesisCancer cellDrug deliveryCancer researchOsteosarcomaDrug Screening Assays Antitumormedicine.drugMaterials Science and Engineering: C
researchProduct